Versigent Analyst Price Targets - Benzinga

Versigent PLC

VGNTNYSE

Trade with Public

Trade with Public

$41.06

-1.26-2.98%

Últ. Act.: Oct 30, 4:00 PM

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

Versigent Analyst Price Targets - Benzinga

Versigent Analyst Price Targets

Wall Street analyst price targets and consensus rating for Versigent (VGNT).

Price Target Range — 3 Quarters

Analyst Consensus — 8 Analysts

8Buy

Consensus RatingBuy# Analysts8Avg. Consensus PT$56Upside to Avg. PT+36.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 12, 2026	RBC Capital	Tom Narayan	PT Raise	Outperform	$52→$53
Oct 6, 2026	Goldman Sachs	Mark Delaney	PT Cut	Buy	$59→$58
Aug 13, 2026	Argus Research	Bill Selesky	PT Raise	Buy	$50→$54
Aug 10, 2026	Evercore ISI Group	Chris McNally	PT Raise	Outperform	$60→$65
Aug 5, 2026	TD Cowen	Itay Michaeli	PT Raise	Buy	$49→$58
Aug 5, 2026	RBC Capital	Tom Narayan	Upgrade	Sector Perform→Outperform	$41→$52
Aug 5, 2026	Wells Fargo	Colin Langan	PT Raise	Overweight	$48→$56
Jul 20, 2026	Goldman Sachs	Mark Delaney	Initiate	Buy	$48
Jul 13, 2026	RBC Capital	Tom Narayan	PT Raise	Sector Perform	$34→$41
Jul 9, 2026	UBS	Joseph Spak	PT Cut	Buy	$58→$55
Jul 8, 2026	Deutsche Bank	Edison Yu	Upgrade	Hold→Buy	$50
Jun 25, 2026	Wells Fargo	Colin Langan	PT Raise	Overweight	$42→$48
Jun 5, 2026	UBS	Joseph Spak	PT Raise	Buy	$49→$58
May 6, 2026	UBS	Joseph Spak	PT Raise	Buy	$43→$49
May 6, 2026	TD Cowen	Itay Michaeli	PT Raise	Buy	$47→$49
May 6, 2026	Wells Fargo	Colin Langan	PT Raise	Overweight	$35→$42
Apr 28, 2026	Deutsche Bank	Edison Yu	Initiate	Hold	$35
Apr 14, 2026	UBS	Joseph Spak	Initiate	Buy	$43
Apr 6, 2026	Wells Fargo	Colin Langan	Initiate	Overweight	$35

Analyst Ratings News

PRO
RBC Capital Maintains Outperform on Versigent, Raises Price Target to $53

RBC Capital analyst Tom Narayan maintains Versigent (NYSE:VGNT) with a Outperform and raises the price target from $52 to $53.

Benzinga Newsdesk

PRO
Goldman Sachs Maintains Buy on Versigent, Lowers Price Target to $58

Goldman Sachs analyst Mark Delaney maintains Versigent (NYSE:VGNT) with a Buy and lowers the price target from $59 to $58.

Benzinga Newsdesk

PRO
Argus Research Maintains Buy on Versigent, Raises Price Target to $54

Argus Research analyst Bill Selesky maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $50 to $54.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Versigent, Raises Price Target to $65

Evercore ISI Group analyst Chris McNally maintains Versigent (NYSE:VGNT) with a Outperform and raises the price target from $60 to $65.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Versigent, Raises Price Target to $58

TD Cowen analyst Itay Michaeli maintains Versigent (NYSE:VGNT) with a Buy and raises the price target from $49 to $58.

Benzinga Newsdesk

PRO
RBC Capital Upgrades Versigent to Outperform, Raises Price Target to $52

RBC Capital analyst Tom Narayan upgrades Versigent (NYSE:VGNT) from Sector Perform to Outperform and raises the price target from $41 to $52.

Benzinga Newsdesk